No Longer a Need for NIRP Crash Indicator Signals
2017 STANY Capital Markets Conference: Navigating Through Political and FinTech Disruption
dynaCERT Announces $2.7 Million in Sales, New Product Developments and Results of 2017 Annual Meeting of Shareholders
The App That Offers Wifi in Exchange for (What Else?) Your Data...
Crude Oil at Critical Junction
Daniel Teper of Immune Pharmaceuticals explains the potential of bertilimumab, his company's leading product candidate.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).